TER TERADYNE, INC
Price Chart
Executive Summary
JP Morgan double-upgraded Teradyne (TER) from Neutral to Overweight on April 30, 2026, maintaining a $400 price target. The call is contrarian relative to consensus: 16 of 23 analysts rate TER Buy/Strong Buy, 6 Hold, 1 Sell, with a mean target of $369.53 implying 5.0% downside from the current $389.14. JP Morgan's 55% accuracy on 5,703 calls and 5.6% average return rank below average among firms covering TER, where Evercore ISI and Craig-Hallum lead at 100% accuracy. Momentum is strongly bullish: 30-day EPS revisions show 14 upward revisions for the current year and 15 for next year, with zero downgrades. Insider selling is heavy — $3.9M in sales over the past week by the CEO and directors — diverging from the upgrade. Institutional activity is mixed: Norges Bank initiated a $399M position and Two Sigma added $91M, while FMR trimmed $326M. Short interest at 60.6% of TRF volume signals elevated bearish positioning. The upgrade adds bullish fuel, but insider sales and a below-average firm track record temper conviction.
Impact Score
Consensus & Targets
Consensus is heavily bullish: 5 Strong Buy, 11 Buy, 6 Hold, 1 Sell, 0 Strong Sell across 23 analysts. 70% of analysts rate the stock a Buy or Strong Buy, with only 4% at Sell. The consensus direction is clearly positive.
Current price: $389.14. Mean target: $369.53 (implied -5.0% downside). Median: $387. High: $470. Low: $270. JP Morgan's $400 PT sits above the mean and median, in the 70th percentile of the range, indicating an above-consensus bullish view.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-04-30 | JP Morgan | upgrade | Overweight | $400.00 |
| 2026-04-30 | Citigroup | maintain | Buy | $400.00 |
| 2026-04-30 | Goldman Sachs | maintain | Buy | $350.00 |
| 2026-04-30 | Evercore ISI Group | maintain | Outperform | $370.00 |
| 2026-04-28 | Stifel | maintain | Buy | $390.00 |
| 2026-04-28 | Evercore ISI Group | maintain | Outperform | $430.00 |
| 2026-04-21 | UBS | maintain | Buy | $440.00 |
| 2026-04-16 | JP Morgan | maintain | Neutral | $400.00 |
| 2026-04-09 | Susquehanna | maintain | Positive | — |
| 2026-04-09 | Cantor Fitzgerald | maintain | Overweight | — |
30-day analyst activity shows 0 upgrades and 0 downgrades, but EPS revisions are strongly positive: 14 upward revisions for the current fiscal year (0 down), 15 for next year (0 down), and 12 for the next quarter (2 down). Estimates are being revised higher across all timeframes, with the current-year EPS estimate rising 14.2% from $6.29 to $7.18 over 30 days.
Firm Track Record — JP Morgan
JP Morgan accuracy: 55% on 5703 calls | avg return: 5.6%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 13 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Craig-Hallum | 100% | 2/2 | 2.4% | top tier |
| Evercore ISI Group | 100% | 3/3 | 55.2% | top tier |
| Stifel | 71% | 5/7 | 39% | top tier |
| Morgan Stanley | 60% | 3/5 | 43.9% | above average |
| UBS | 57% | 4/7 | 23.6% | above average |
| Baird | 50% | 2/4 | 3.4% | below average |
| Susquehanna | 50% | 3/6 | 7.1% | below average |
| Northland Capital Markets | 40% | 2/5 | -19.6% | below average |
| Goldman Sachs | 38% | 3/8 | 21.1% | below average |
| JP Morgan | 38% | 3/8 | 8.7% | below average |
JP Morgan has a 55% accuracy rate on 5,703 calls with a 5.6% average return, placing it below average among firms covering TER. Top performers are Evercore ISI (100% on 3 calls, +55.2% avg return) and Craig-Hallum (100% on 2 calls, +2.4%). Worst: Keybanc (0% on 6 calls, -4.8% avg return). JP Morgan's track record on TER specifically is 38% (3 of 8 calls), below its firmwide average.
Earnings Estimates
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| 0y | $7.18 | $6.32 — $8.03 | $4.5B | ↑14 ↓0 |
| +1q | $1.38 | $0.82 — $1.84 | $1.0B | ↑11 ↓0 |
| +1y | $9.51 | $7.10 — $11.47 | $5.5B | ↑15 ↓0 |
| 0q | $2.04 | $1.86 — $2.14 | $1.2B | ↑10 ↓0 |
Cross-Platform Signals
Insider trading diverges sharply: $3.9M in sales over the past week, including CEO Smith Gregory ($2.9M) and directors Poulin ($581K) and Matz ($411K). This is a bearish contra-signal to the upgrade. Congressional activity is mildly bullish: Rep. Michael McCaul (R-TX) bought $15K-$50K on April 29. Institutional flows are mixed: Norges Bank ($399M new), Two Sigma ($91M added), and Wells Fargo ($43.5M added) are bullish; FMR ($326M trimmed) and Renaissance Technologies (near-exit) are bearish. Short interest at 60.6% of TRF volume is elevated, suggesting crowded bearish positioning that could fuel a squeeze.
Actionable Insight
The double upgrade from JP Morgan adds bullish momentum to a stock already seeing strong EPS revisions and institutional inflows, but heavy insider selling and a below-average firm track record warrant caution. Traders should watch for a break above $400 on volume as confirmation; failure to hold gains could signal the insider sales are more informative.
Documents Analyzed
Report based on filing metadata.
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 30, 2026
10d ago
|
ANALYST-UPGRADE
| $345.29 $359.63 | ▲ +4.15% | ▲ +1.81% | $374.69 (+8.51%) |
|
May 26, 2026
14d ago
|
Insider Cluster
| $375.83 $392.62 | ▲ +4.47% | ▲ +3.26% | $374.69 (−0.30%) |
|
May 26, 2026
14d ago
|
Insider Cluster
| $375.83 $392.62 | ▲ +4.47% | ▲ +3.26% | $374.69 (−0.30%) |
|
May 19, 2026
21d ago
|
Insider Cluster
| $321.40 $372.75 | ▲ +15.98% | ▲ +13.73% | $374.69 (+16.58%) |
|
May 16, 2026
24d ago
|
ANALYST-UPGRADE
| $192.14 $198.34 | ▲ +3.23% | ▲ +1.89% | $374.69 (+95.01%) |
|
Apr 30, 2026
5w ago
|
ANALYST-UPGRADE
| $345.42 $354.11 | ▲ +2.52% | ▲ +0.17% | $374.69 (+8.47%) |
|
Apr 16, 2026
7w ago
|
ANALYST-UPGRADE
| $365.92 $400.99 | ▲ +9.58% | ▲ +8.60% | $374.69 (+2.40%) |
|
Apr 2, 2026
9w ago
|
Insider Cluster
| $309.61 $367.99 | ▲ +18.86% | ▲ +15.24% | $374.69 (+21.02%) |
|
Mar 27, 2026
10w ago
|
DEFA14A
| $295.61 $315.43 | ▲ +6.70% | ▲ +2.84% | $374.69 (+26.75%) |
|
Feb 28, 2026
14w ago
|
Institutional Cluster
| $325.83 $296.44 | ▼ −9.02% | ▼ −7.81% | $374.69 (+15.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access